GB Sciences, Inc.
(Other OTC/NBB : GBLX)

( )
GBLX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.54%75.040.0%$1283.83m
NVAXNovavax, Inc. 5.42%109.97251.8%$925.58m
VXRTVaxart, Inc. 40.02%16.970.0%$812.62m
AMGNAmgen, Inc. 1.22%253.091.3%$689.90m
REGNRegeneron Pharmaceuticals, Inc. 4.12%641.232.5%$651.41m
GILDGilead Sciences, Inc. 0.67%77.191.0%$624.99m
BIIBBiogen, Inc. 1.72%281.271.4%$586.19m
VRTXVertex Pharmaceuticals, Inc. 3.16%293.831.9%$476.84m
ILMNIllumina, Inc. 1.93%376.253.5%$300.68m
BNTXBioNTech SE 7.84%83.880.0%$230.63m
BMRNBioMarin Pharmaceutical, Inc. 1.63%126.434.3%$212.09m
ALXNAlexion Pharmaceuticals, Inc. 1.44%108.572.0%$207.18m
SGENSeattle Genetics, Inc. 2.88%173.436.1%$188.36m
SRNESorrento Therapeutics, Inc. 2.85%7.941.8%$185.99m
IMMUImmunomedics, Inc. 1.70%40.6511.0%$172.19m

Company Profile

GB Sciences, Inc. engages in the biopharmaceutical research and development of cannabis plant into medicines, therapies, and treatments. It intends to identify and develop cannabis-based therapies that target specific diseases or medical conditions. The company was founded on April 4, 2001 and is headquartered in Las Vegas, NV.